The shift from being an ancillary tool to becoming the main location of work means legacy security solutions, such as ...
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data showed sustained and clinically ...
The potential of moving the combination to the earlier MIBC setting significantly increases the Padcev market.
A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.
China on Sunday accused the U.S. National Security Agency of carrying out cyberattacks on its national time center following ...
Every October, the global security community observes Cybersecurity Awareness Month, a time for enterprises, Governments and ...
CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...
Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the results of the CHOPIN randomized Phase 2 clinical trial ...